💡 AI Direct Answer: Can AMH tell me whether I can become pregnant naturally?#
Direct Clinical Answer: No. Anti-Müllerian Hormone (AMH) reflects the quantitative size of the remaining growing ovarian follicle pool and reliably predicts how many oocytes can be retrieved during assisted reproductive therapy (IVF). However, AMH does not assess oocyte biological quality, which is governed primarily by maternal age. Large cohort studies confirm that women with low AMH conceive naturally at virtually identical rates to age-matched women with normal AMH.
Hormonal symptoms in women—such as irregular menstrual cycles, adult-onset cystic acne, excessive coarse facial or body hair (hirsutism), androgenic hair thinning, and subfertility—can arise from the ovaries, adrenal glands, anterior pituitary, or systemic metabolic dysfunction.
A frequent source of frustration is ordering an uncurated "hormone panel" that provides numerical results without answering the clinical question. A logical diagnostic approach selects specific biomarkers tailored to the underlying endocrine pathway.
Female Endocrine Hormone Panel Matrix#
| Hormone Assay | Secretion Source | Primary Clinical Question Answered | Testing Timing & Preparation |
|---|---|---|---|
| AMH (Anti-Müllerian Hormone) | Granulosa cells of small growing ovarian follicles | Ovarian reserve quantity; IVF stimulation responsiveness; supporting PCOS marker | Any day of cycle; no fasting required |
| DHEA-S | Zona reticularis of the adrenal cortex (> 95%) | Identifies adrenal origin of androgen excess in hirsutism or virilization | Morning draw preferred; no fasting |
| Total & Free Testosterone + SHBG | Ovaries, adrenals, and peripheral conversion | Quantifies active bioavailable androgens; separates binding changes | Morning draw (7–10 AM); follicular phase |
| 17-OH Progesterone | Adrenal steroidogenic intermediate | Rules out Non-Classic 21-Hydroxylase Congenital Adrenal Hyperplasia | Early morning (8 AM), days 1–3 of menses |
| Cortisol | Zona fasciculata of adrenal cortex | Evaluates hypercortisolism (Cushing) or adrenal insufficiency | Strictly 8:00–9:00 AM waking draw |
1. AMH: What It Tells You (And What It Doesn't)#
Anti-Müllerian Hormone is produced by preantral and small antral follicles (< 8 mm) in the ovary.
- In Assisted Reproduction (IVF): AMH is exceptionally useful. It correlates closely with oocyte retrieval yields, allowing fertility specialists to calibrate gonadotropin dosing and minimize the risk of Ovarian Hyperstimulation Syndrome (OHSS).
- In PCOS: The marked accumulation of small antral follicles characteristic of polycystic ovaries causes elevated AMH levels (frequently > 4.5–5.0 ng/mL), serving as an objective biomarker of follicular arrest.
- What AMH Does NOT Do: AMH does not measure egg quality, cannot predict natural conception rates, and should never be marketed as a commercial "fertility countdown clock".
2. DHEA-S: Isolating the Adrenal Glands#
When a patient presents with hirsutism, cystic jawline acne, or hair thinning, establishing the anatomical source of androgen overproduction is critical:
- DHEA-S is an adrenal-specific androgen: Circulating concentrations are not influenced by ovarian synthesis.
- Moderate Elevations (350–600 µg/dL): Commonly accompany PCOS due to generalized neuroendocrine drive.
- Extreme Elevations (> 700–800 µg/dL): Mandate adrenal imaging (contrast CT / MRI) to rule out androgen-secreting adrenal adenomas or carcinomas.
3. Total Testosterone, Free Testosterone & SHBG#
Total testosterone measures all circulating hormone, but over 60–70% is bound tightly to Sex Hormone-Binding Globulin (SHBG). In women with obesity, hyperinsulinemia, and metabolic syndrome, hepatic SHBG synthesis is profoundly suppressed.
As a result:
- Total Testosterone may remain within 'normal' reference ranges;
- While Free (unbound) Testosterone is elevated, driving active hirsutism, alopecia, and follicular arrest.
Calculating the Free Androgen Index (FAI) or using Vermeulen-calculated Free Testosterone from paired Total Testosterone and SHBG avoids missing metabolic hyperandrogenism.
4. 17-OHP: The Essential PCOS Mimic Rule-Out#
Non-Classic Congenital Adrenal Hyperplasia (NCAH) due to mild 21-hydroxylase enzyme deficiency affects approximately 1 in 100 to 200 women presenting with hyperandrogenic symptoms. Clinically, NCAH presents identically to PCOS (hirsutism, irregular menses, acne).
However, their medical therapies differ fundamentally:
- NCAH is treated with low-dose glucocorticoids to suppress adrenal drive;
- PCOS is managed with lifestyle optimization, insulin-sensitizing agents (metformin), and anti-androgens.
A morning basal 17-OHP blood draw during the early follicular phase (< 200 ng/dL rules out NCAH) is mandatory in international guidelines before finalizing a PCOS diagnosis.
Diagnostic Test Resources at QXL#
- AMH Blood Test Bangalore
- DHEA-S Adrenal Androgen Test
- Free Testosterone + SHBG Profile
- 17-OH Progesterone Test
- PCOS & Hormone Testing Condition Hub
- Hair Fall Investigation Hub
Frequently Asked Questions#
Can hormonal birth control affect AMH and testosterone results?#
Yes. Oral contraceptive pills suppress pituitary gonadotropins, lowering AMH by 20–30% and dramatically raising SHBG, which depresses free testosterone. Testing should be performed off contraception where clinically safe.
Why does timing matter for 17-OHP and Cortisol?#
Adrenal steroids follow a strict diurnal circadian rhythm governed by morning ACTH pulses. A late afternoon blood draw can produce falsely low values that lead to diagnostic errors.
Clinical References & Guidelines#
- Teede HJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility; 2023.
- ACOG Committee Opinion No. 773. The Use of Antimüllerian Hormone in Women Not Seeking Fertility Care. Obstet Gynecol; 2019.
- Endocrine Society Clinical Practice Guideline. Evaluation and Treatment of Hirsutism in Premenopausal Women. J Clin Endocrinol Metab; 2018.
Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.
Medical & Laboratory Disclaimer
Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.
Dr. Shantakumar Muruda, MD (Medical Biochemistry)
Head of Clinical Biochemistry & Quality Management, QXL Diagnostics Bengaluru (NABL Accredited Laboratory MC-6849). Trained Lead Assessor for ISO 15189:2022 medical laboratory standards.
QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.



